Physician profile
Francisco Jeannot
NPI 1285655860
$1,023.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.68 · 2020: $55.04 · 2021: $101 · 2023: $749 · 2024: $33.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $568 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $568.13 |
| Food and Beverage | $213.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $696.81 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.74 | 2021-2024 | Relistor |
| Pfizer INC. | $90.49 | 2019-2020 | |
| Ibsa Pharma INC. | $21.56 | 2021 | |
| Redhill Biopharma INC. | $18.60 | 2021 | |
| Virtus Pharmaceuticals LLC | $18.60 | 2021 | |
| Medtronic USA, INC. | $14.12 | 2019 | |
| Kaleo, INC. | $13.31 | 2019 | |
| Forte Bio-Pharma LLC | $11.44 | 2021 | |
| Horizon Therapeutics Plc | $11.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Jeannot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.